Nutriband Inc.
General ticker "NTRB" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $71.5M (TTM average)
Nutriband Inc. follows the US Stock Market performance with the rate: 21.4%.
Estimated limits based on current volatility of 4.0%: low 4.56$, high 4.94$
Factors to consider:
- Total employees count: 150 as of 2017
- US accounted for 100.0% of revenue in the fiscal year ended 2024-01-31
- Top business risk factors: No commercial products, Funding dependency, FDA approval delays, Clinical trial success, Regulatory and compliance
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-01-31 to 2027-01-31
- 2025-01-31 to 2026-01-31 estimated range: [4.13$, 9.86$]
- 2026-01-31 to 2027-01-31 estimated range: [3.01$, 7.54$]
Financial Metrics affecting the NTRB estimates:
- Negative: with PPE of -12.4 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -5.58 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 86.06 > 63.39
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of -0.11 > -0.66
Short-term NTRB quotes
Long-term NTRB plot with estimates
Financial data
| YTD | 2023-01-31 | 2024-01-31 | 2025-01-31 |
|---|---|---|---|
| Operating Revenue | $2.08MM | $2.09MM | $2.14MM |
| Operating Expenses | $6.55MM | $6.96MM | $8.83MM |
| Operating Income | $-4.48MM | $-4.87MM | $-6.69MM |
| Non-Operating Income | $-0.01MM | $-0.61MM | $-3.79MM |
| Interest Expense | $0.01MM | $0.08MM | $0.02MM |
| R&D Expense | $0.98MM | $1.96MM | $3.12MM |
| Income(Loss) | $-4.48MM | $-5.49MM | $-10.48MM |
| Profit(Loss)* | $-4.81MM | $-5.49MM | $-10.48MM |
| Stockholders Equity | $8.57MM | $6.44MM | $6.43MM |
| Inventory | $0.23MM | $0.17MM | $0.21MM |
| Assets | $9.46MM | $7.52MM | $7.47MM |
| Operating Cash Flow | $-2.99MM | $-3.53MM | $-4.63MM |
| Capital expenditure | $0.08MM | $0.05MM | $0.09MM |
| Investing Cash Flow | $-0.08MM | $-0.05MM | $-0.09MM |
| Financing Cash Flow | $0.16MM | $2.09MM | $8.54MM |
| Earnings Per Share** | $-0.57 | $-0.69 | $-0.99 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.